Ambalal Sarabhai Enterprises Ltd.
Snapshot View

29.25 -0.50 ▼-1.7%

23 September 2022, 04:01:00 PM
Volume: 79,808

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ase.life
Market Cap 224.15 Cr.
Enterprise Value(EV) 221.53 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 2.90 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 10.09 Trailing Twelve Months Ending 2022-06
Industry PE 30.97 Trailing Twelve Months Ending 2022-06
Book Value / Share 16.01 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.83 Calculated using Price: 29.25
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 7.66 Cr. 76,633,296 Shares
FaceValue 10
Company Profile
Ambalal Sarabhai Enterprises is a Baroda-based pharmaceutical manufacturing company which was incorporated in 1977. It is one of the company belonging to the Sarabhai Group. The Group's principal activity is manufacture and marketing of pharmaceutical products and bulk drugs. The company's plants are located at Vadodara and Ahmedabad.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.68%
1 Week
-4.26%
1 Month
+0.34%
3 Month
-4.72%
6 Month
-11.63%
1 Year
-7.87%
2 Year
+63.87%
5 Year
+293.67%
10 Year
+611.68%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) -66.09 -256.13 328.25 -57.92 4.20 7.01 40.95 34.12
Return on Capital Employed (%) -12.98 -17.91 10.08 107.14 -11.94 16.34 13.17 27.14 29.83
Return on Assets (%) -8.29 -9.58 -3.51 25.83 -10.30 0.62 0.99 7.84 10.36

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 18 -2 -9 39 25 27 31 45 74 120
Non Curr. Liab. 17 59 15 13 6 11 9 5 5 5
Curr. Liab. 175 155 163 153 124 155 171 133 129 105
Minority Int. 0 0 0 0
Equity & Liab. 210 211 169 204 155 193 211 183 208 230
Non Curr. Assets 106 144 100 92 82 80 95 79 87 110
Curr. Assets 105 67 68 112 73 114 116 104 121 120
Misc. Exp. not W/O
Total Assets 210 211 169 204 155 193 211 183 208 230

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 100 105 125 132 134 125 152 134 164 198
Other Income 16 3 13 95 6 25 5 24 31 14
Total Income 117 108 137 227 140 150 157 158 194 212
Total Expenditure -111 -113 -129 -145 -145 -137 -146 -135 -165 -178
PBIDT 6 -6 9 82 -5 13 11 22 29 34
Interest -9 -11 -10 -4 -5 -3 -3 -4 -3 -2
Depreciation -14 -3 -5 -17 -4 -2 -2 -3 -2 -2
Taxation -1 -1 -1 -14 -5 -7 -4 -1 -3 -6
Exceptional Items 0
PAT -18 -20 -7 48 -19 1 2 15 20 24
Minority Interest
Share Associate 0 0 2 -1 9 -2
Other Related Items
Consolidated Net Profit -18 -20 -7 48 -18 1 4 14 29 22
Adjusted EPS -2 -3 -1 6 -2 0 1 2 4 3

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -13 -3 11 -8 -75 5 -7 19 -7 -2
Cash Fr. Inv. 11 0 -1 10 80 -3 18 -9 17 10
Cash Fr. Finan. 1 3 -8 -1 -3 -6 -2 -6 -14 -6
Net Change -1 -1 2 1 2 -4 8 3 -4 2
Cash & Cash Eqvt 7 6 8 8 10 5 14 17 13 15

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 30.76 30.76 30.76 30.76 30.76 30.76 30.76 30.76 30.76
Public 69.24 69.24 69.24 69.24 69.24 69.24 69.24 69.24 69.24
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 23 Sep 2022
Shareholder Meeting- Voting Results -Scrutinizer''''s Report
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the voting results of the Annual General Meeting of the Company held on Wednesday 21st September 2022 through Video Conferencing / Other Audio Video Means ("VC/OAVM" ) in the prescribed format along with Scrutinizers Report. We request you to kindly take the above on record.
Thu, 22 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
With reference to the captioned subject we are enclosing herewith Declaration of results of remote e-voting and e-voting during the 44th Annual General Meeting of the Company held on Wednesday September 21 2022 at 11:00 A.M. through Video Conferencing/ Other Audio Visual Means along with Scrutinizers Report.
Thu, 22 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Para A of Part A of Schedule III of the Listing Regulations please find enclosed the summary of proceedings of the 44th Annual General Meeting (AGM) of the Company held on Wednesday September 21 2022.We request you to kindly take the above on record.

Technical Scans View Details >>

Fri, 23 Sep 2022
High Delivery Percentage High Delivery Percentage
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase 2 Years High Increase 2 Years
High Increase 5 Years High Increase 5 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,930.76 920.80 +1.5%
Divi's Laboratories Ltd. 96,681.00 3,641.90 +1.7%
Cipla Ltd. 86,429.87 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. 68,908.63 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. 63,570.07 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. 51,257.56 1,514.50 -1.6%
Max Healthcare Institute Ltd. 41,385.83 426.80 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.80 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.13 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 34.73 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.04 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.96 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 63.99 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 65.59 426.80 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.41 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.78 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-06 4.02 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.70 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.02 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.43 426.80 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 426.80 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 426.80 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 426.80 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 920.80 +1.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,641.90 +1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,071.00 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,139.50 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,421.20 -4.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,514.50 -1.6%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 426.80 -0.1%

FAQ's On Ambalal Sarabhai Enterprises Ltd.

What is Ambalal Sarabhai Ent share price?

Can I buy Ambalal Sarabhai Ent shares now?

What is the Market Cap of Ambalal Sarabhai Ent?

What are the key metrics to analyse Ambalal Sarabhai Ent?

What is the 52 Week High and Low of Ambalal Sarabhai Ent?

What is the trend of Ambalal Sarabhai Ent share price?